Association Between Three Atopic Triad and Retinal Vein Occlusion Risk: A Nationwide Population-Based Study

References

• Rogers S, McIntosh RL, Cheung N, et al. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117(2):313–319 e311. doi:10.1016/j.ophtha.2009.07.017.
   PubMed Web of Science ®Google Scholar
• Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion. The eye disease case-control study group. Ophthalmology. 1993;100(3):423–428. doi:10.1016/s0161-6420(93)31633-7.
   PubMed Web of Science ®Google Scholar
• Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology. 1999;106(11):2054–2062. doi:10.1016/S0161-6420(99)90483-9.
   PubMed Web of Science ®Google Scholar
• Trope GE, Lowe GD, McArdle BM, et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol. 1983;67(3):137–142. doi:10.1136/bjo.67.3.137.
   PubMed Web of Science ®Google Scholar
• Janssen MC, den Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost. 2005;93(6):1021–1026. doi:10.1160/TH04-11-0768.
   PubMed Web of Science ®Google Scholar
• Noma H, Funatsu H, Mimura T, Eguchi S, Shimada K. Inflammatory factors in major and macular branch retinal vein occlusion. Ophthalmologica. 2012;227(3):146–152. doi:10.1159/000335047.
   PubMed Web of Science ®Google Scholar
• Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam. 2013;2013:438412. doi:10.1155/2013/438412.
   PubMedGoogle Scholar
• O’Mahoney PR, Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol. 2008;126(5):692–699. doi:10.1001/archopht.126.5.692.
   PubMedGoogle Scholar
• Yen YC, Weng SF, Chen HA, Lin YS. Risk of retinal vein occlusion in patients with systemic lupus erythematosus: a population-based cohort study. Br J Ophthalmol. 2013;97(9):1192–1196. doi:10.1136/bjophthalmol-2013-303265.
   PubMed Web of Science ®Google Scholar
• Bucciarelli P, Passamonti SM, Gianniello F, Artoni A, Martinelli I. Thrombophilic and cardiovascular risk factors for retinal vein occlusion. Eur J Intern Med. 2017;44:44–48. doi:10.1016/j.ejim.2017.06.022.
   PubMed Web of Science ®Google Scholar
• Park SJ, Choi NK, Park KH, Woo SJ. Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea, 2008 through 2011: preponderance of women and the impact of aging. Ophthalmology. 2014;121(6):1274–1280. doi:10.1016/j.ophtha.2013.12.024.
   PubMed Web of Science ®Google Scholar
• Rao VN, Ulrich JN, Viera AJ, Parlin A, Fekrat S, Chavala SH. Ambulatory blood pressure patterns in patients with retinal vein occlusion. Retina. 2016;36(12):2304–2310. doi:10.1097/IAE.0000000000001071.
   PubMed Web of Science ®Google Scholar
• Werther W, Chu L, Holekamp N, Do DV, Rubio RG. Myocardial infarction and cerebrovascular accident in patients with retinal vein occlusion. Arch Ophthalmol. 2011;129(3):326–331. doi:10.1001/archophthalmol.2011.2.
   PubMedGoogle Scholar
• Ponto KA, Elbaz H, Peto T, et al. Prevalence and risk factors of retinal vein occlusion: the Gutenberg health study. J Thromb Haemost. 2015;13(7):1254–1263. doi:10.1111/jth.12982.
   PubMed Web of Science ®Google Scholar
• Fang LJ, Dong L, Li YF, Wei WB. Retinal vein occlusion and chronic kidney disease: a meta-analysis. Eur J Ophthalmol. 2021;31(4):1945–1952. doi:10.1177/1120672120937669.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Stem M, Talwar N, Musch DC, Besirli CG, Stein JD. Risk factors associated with developing branch retinal vein occlusion among enrollees in a United States managed care plan. Ophthalmology. 2014;121(10):1939–1948. doi:10.1016/j.ophtha.2014.04.045.
   PubMed Web of Science ®Google Scholar
• Bakhoum CY, Madala S, Long CK, et al. Retinal vein occlusion is associated with stroke independent of underlying cardiovascular disease. Eye (Lond). 2023;37(4):764–767. doi:10.1038/s41433-022-02038-x.
   PubMed Web of Science ®Google Scholar
• Zhong C, You S, Zhong X, Chen GC, Xu T, Zhang Y. Retinal vein occlusion and risk of cerebrovascular disease and myocardial infarction: a meta-analysis of cohort studies. Atherosclerosis. 2016;247:170–176. doi:10.1016/j.atherosclerosis.2016.02.024.
   PubMed Web of Science ®Google Scholar
• Rhee TM, Choi EK, Han KD, Lee SR, Oh S. Impact of the combinations of allergic diseases on myocardial infarction and mortality. J Allergy Clin Immunol Pract. 2021;9(2):872–880 e874. doi:10.1016/j.jaip.2020.09.008.
   PubMed Web of Science ®Google Scholar
• Lim WH, Choi EK, Han KD, et al. Proteinuria detected by urine dipstick test as a risk factor for atrial fibrillation: a nationwide population-based study. Sci Rep. 2017;7(1):6324. doi:10.1038/s41598-017-06579-0.
   PubMedGoogle Scholar
• Bae WJ, Choi JB, Moon HW, et al. Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study. J Cancer. 2018;9(3):488–493. doi:10.7150/jca.22107.
   PubMed Web of Science ®Google Scholar
• Kim J, Lim DH, Han K, et al. Retinal vein occlusion is associated with low blood high-density lipoprotein cholesterol: a nationwide cohort study. Am J Ophthalmol. 2019;205:35–42. doi:10.1016/j.ajo.2019.04.001.
   PubMed Web of Science ®Google Scholar
• Han G, Han J, Han K, Youn J, Chung TY, Lim DH. Visual acuity and development of Parkinson’s disease: a nationwide cohort study. Mov Disord. 2020;35(9):1532–1541. doi:10.1002/mds.28184.
   PubMed Web of Science ®Google Scholar
• Rath EZ, Frank RN, Shin DH, Kim C. Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992;99(4):509–514. doi:10.1016/s0161-6420(92)31940-2.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol. 2001;131(1):61–77. doi:10.1016/s0002-9394(00)00709-1.
   PubMed Web of Science ®Google Scholar
• Elman MJ, Bhatt AK, Quinlan PM, Enger C. The risk for systemic vascular diseases and mortality in patients with central retinal vein occlusion. Ophthalmology. 1990;97(11):1543–1548. doi:10.1016/s0161-6420(90)32379-5.
   PubMed Web of Science ®Google Scholar
• Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies. Ophthalmology. 2005;112(4):540–547. doi:10.1016/j.ophtha.2004.10.039.
   PubMed Web of Science ®Google Scholar
• Mitchell P, Smith W, Chang A. Prevalence and associations of retinal vein occlusion in Australia. The blue mountains eye study. Arch Ophthalmol. 1996;114(10):1243–1247. doi:10.1001/archopht.1996.01100140443012.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Zimmerman MB. Branch retinal vein occlusion: natural history of visual outcome. JAMA Ophthalmol. 2014;132(1):13–22. doi:10.1001/jamaophthalmol.2013.5515.
   PubMed Web of Science ®Google Scholar
• Risk factors for branch retinal vein occlusion. The eye disease case-control study group. Am J Ophthalmol. 1993;116(3):286–296. doi:10.1016/S0002-9394(14)71345-5.
   PubMed Web of Science ®Google Scholar
• Rose K, Flanagan JG, Patel SR, Cheng R, Hudson C. Retinal blood flow and vascular reactivity in chronic smokers. Invest Ophthalmol Vis Sci. 2014;55(7):4266–4276. doi:10.1167/iovs.14-14022.
   PubMed Web of Science ®Google Scholar
• Tuleta I, Skowasch D, Aurich F, Feng Y-M, et al. Asthma is associated with atherosclerotic artery changes. PLoS One. 2017;12(10):e0186820. doi:10.1371/journal.pone.0186820.
   PubMed Web of Science ®Google Scholar
• Liu CL, Wang Y, Liao M, et al. Allergic lung inflammation promotes atherosclerosis in apolipoprotein E-deficient mice. Transl Res. 2016;171:1–16. doi:10.1016/j.trsl.2016.01.008.
   PubMed Web of Science ®Google Scholar
• Wang L, Gao S, Xu W, et al. Allergic asthma accelerates atherosclerosis dependent on Th2 and Th17 in apolipoprotein E deficient mice. J Mol Cell Cardiol. 2014;72:20–27. doi:10.1016/j.yjmcc.2014.02.005.
   PubMed Web of Science ®Google Scholar
• Tattersall MC, Guo M, Korcarz CE, et al. Asthma predicts cardiovascular disease events: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35(6):1520–1525. doi:10.1161/ATVBAHA.115.305452.
   PubMed Web of Science ®Google Scholar
• Libby P, Buring JE, Badimon L, et al. Atherosclerosis. Nat Rev Dis Primers. 2019;5(1):56. doi:10.1038/s41572-019-0106-z.
   PubMed Web of Science ®Google Scholar
• Ha J, Lee SW, Yon DK. Ten-year trends and prevalence of asthma, allergic rhinitis, and atopic dermatitis among the Korean population, 2008-2017. Clin Exp Pediatr. 2020;63(7):278–283. doi:10.3345/cep.2019.01291.
   PubMedGoogle Scholar
• Shin KU, Lee JY, Han K, Song SJ. Sex-specific age threshold for increased risk of retinal vein occlusion in koreans. Thromb Res. 2018;167:60–63. doi:10.1016/j.thromres.2018.05.020.
   PubMed Web of Science ®Google Scholar
• Rohrbach MS, Wheatley CL, Slifman NR, Gleich GJ. Activation of platelets by eosinophil granule proteins. J Exp Med. 1990;172(4):1271–1274. doi:10.1084/jem.172.4.1271.
   PubMed Web of Science ®Google Scholar
• Moosbauer C, Morgenstern E, Cuvelier SL, et al. Eosinophils are a major intravascular location for tissue factor storage and exposure. Blood. 2007;109(3):995–1002. doi:10.1182/blood-2006-02-004945.
   PubMed Web of Science ®Google Scholar
• Kuzeytemiz M, Demir M, Şentürk M. The relationship between eosinophil and nondipper hypertension. Cor et Vasa. 2013;55(6):e487–e491. doi:10.1016/j.crvasa.2013.07.005.
   Google Scholar
• Demir M, Senturk M, Kuzeytemiz M. The relationship between eosinophil and cardiac syndrome X. Clin Appl Thromb Hemost. 2015;21(4):325–328. doi:10.1177/1076029613502256.
   PubMed Web of Science ®Google Scholar
• Niccoli G, Schiavino D, Belloni F, et al. Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents. Eur Heart J. 2009;30(11):1340–1347. doi:10.1093/eurheartj/ehp120.
   PubMed Web of Science ®Google Scholar
• Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48(1):193–202. doi:10.1016/j.jacc.2006.03.042.
   PubMed Web of Science ®Google Scholar
• Yutani C, Ishibashi-Ueda H, Suzuki T, Kojima A. Histologic evidence of foreign body granulation tissue and de novo lesions in patients with coronary stent restenosis. Cardiology. 1999;92(3):171–177. doi:10.1159/000006967.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Fukui M, Tomiyasu K, et al. Eosinophil count is positively correlated with coronary artery calcification. Hypertens Res. 2012;35(3):325–328. doi:10.1038/hr.2011.191.
   PubMed Web of Science ®Google Scholar
• Steyers CM 3rd, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349. doi:10.3390/ijms150711324.
   PubMed Web of Science ®Google Scholar
• Vena GA, Vestita M, Cassano N. Psoriasis and cardiovascular disease. Dermatol Ther. 2010;23(2):144–151. doi:10.1111/j.1529-8019.2010.01308.x.
   PubMed Web of Science ®Google Scholar
• Kupetsky EA, Mathers AR, Ferris LK. Anti-cytokine therapy in the treatment of psoriasis. Cytokine. 2013;61(3):704–712. doi:10.1016/j.cyto.2012.12.027.
   PubMed Web of Science ®Google Scholar
• Liu CL, Zhang JY, Shi GP. Interaction between allergic asthma and atherosclerosis. Transl Res. 2016;174:5–22. doi:10.1016/j.trsl.2015.09.009.
   PubMed Web of Science ®Google Scholar
• Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G. Allergic rhinitis, asthma, and atherosclerosis in the bruneck and ARMY studies. Arch Intern Med. 2005;165(21):2521–2526. doi:10.1001/archinte.165.21.2521.
   PubMedGoogle Scholar
• Faggiano A, Pivonello R, Spiezia S, et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing’s disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab. 2003;88(6):2527–2533. doi:10.1210/jc.2002-021558.
   PubMed Web of Science ®Google Scholar
• Lupoli R, Ambrosino P, Tortora A, Barba L, Lupoli GA, Di Minno MN. Markers of atherosclerosis in patients with Cushing’s syndrome: a meta-analysis of literature studies. Ann Med. 2017;49(3):206–216. doi:10.1080/07853890.2016.1252055.
   PubMed Web of Science ®Google Scholar
• Reiss AB, Jacob B, Ahmed S, Carsons SE, DeLeon J. Understanding accelerated atherosclerosis in systemic lupus erythematosus: Toward better treatment and prevention. Inflammation. 2021;44(5):1663–1682. doi:10.1007/s10753-021-01455-6.
   PubMed Web of Science ®Google Scholar
• Meyer PW, Anderson R, Ker JA, Ally MT. Rheumatoid arthritis and risk of cardiovascular disease. Cardiovasc J Afr. 2018;29(5):317–321. doi:10.5830/CVJA-2018-018.
   PubMed Web of Science ®Google Scholar